[THE COMBINATION OF EXPRESSION OF MARKERS CR1 AND CR2 (CD35/CD21) IN DIAGNOSTIC OF B-CELL LYMPHOPROLIFERATIVE DISEASES]

Klin Lab Diagn. 2015 Apr;60(4):50-2.
[Article in Russian]

Abstract

The study was carried out to analyze rate of expression of antigens CD35 and CD21 in norm and under different forms of B-cell lymphoproliferative diseases. The level of average intensity of fluorescence of antigens CD35, CD21 and CD200 is compared for different groups of patients with B-cell lymphoproliferative diseases. The established patterns of expression of antigens CD35 and CD21 under B-cell lymphoproliferative diseases permit considering expression of the given markers as a characteristic of differential diagnostic.

Publication types

  • English Abstract

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers, Tumor / blood*
  • Diagnosis, Differential
  • Female
  • Gene Expression Regulation, Leukemic*
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell* / blood
  • Leukemia, Lymphocytic, Chronic, B-Cell* / diagnosis
  • Lymphoma, B-Cell* / blood
  • Lymphoma, B-Cell* / diagnosis
  • Male
  • Middle Aged
  • Neoplasm Proteins / blood*
  • Receptors, Complement 3b / blood*
  • Receptors, Complement 3d / blood*

Substances

  • Biomarkers, Tumor
  • CR1 protein, human
  • Neoplasm Proteins
  • Receptors, Complement 3b
  • Receptors, Complement 3d